Sophisticated in vivo models are paramount for evolving drug research and developing biologic therapeutics.

Our whitepaper delves into the challenges faced by researchers in sourcing appropriate models and how humanized immune system (HIS) models can provide innovative solutions.

You will learn about:

• The significance of HIS models in bridging the gap in preclinical R&D, offering a more relevant human context for testing therapeutic interventions.
• The range of genetically modified NOG variants, each designed to support specific research needs and enhanced immune cell engraftment.
• Comparative Analysis: Insight into the differences between huNOG-EXL and Hu-CD34+ NSG-SGM3 models, ensuring researchers can choose the best fit for their studies.

This whitepaper outlines the capabilities of our NOG models and serves as a valuable resource for researchers looking to improve their drug discovery efforts.

Brought to you by